IRIS
BASSETTI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.249
EU - Europa 3.913
AS - Asia 1.494
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 18
AF - Africa 8
OC - Oceania 4
Totale 28.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.223
UA - Ucraina 1.360
CN - Cina 731
SE - Svezia 635
DE - Germania 597
IT - Italia 560
TR - Turchia 455
IE - Irlanda 272
FI - Finlandia 199
VN - Vietnam 159
GB - Regno Unito 124
SG - Singapore 79
BE - Belgio 33
NL - Olanda 30
IN - India 29
CA - Canada 25
EU - Europa 25
FR - Francia 19
CZ - Repubblica Ceca 16
KR - Corea 15
RS - Serbia 11
RU - Federazione Russa 11
AT - Austria 10
PL - Polonia 10
AR - Argentina 7
BR - Brasile 5
HU - Ungheria 5
PH - Filippine 5
AO - Angola 4
HK - Hong Kong 4
IR - Iran 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PE - Perù 3
CH - Svizzera 2
ES - Italia 2
GH - Ghana 2
JP - Giappone 2
LU - Lussemburgo 2
MM - Myanmar 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
IL - Israele 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 28.711
Salva come PNG Salva come JPEG
Città #
Fairfield 3.666
Woodbridge 3.348
Houston 2.246
Ann Arbor 1.932
Ashburn 1.605
Seattle 1.460
Chandler 1.364
Wilmington 1.308
Cambridge 1.302
Dearborn 815
Jacksonville 685
Izmir 453
Beijing 318
Princeton 299
Dublin 269
Udine 189
San Diego 175
Des Moines 160
Dong Ket 158
Boardman 129
Falls Church 94
Andover 74
Norwalk 64
Hefei 58
Singapore 57
Nanjing 53
Ogden 51
Kunming 38
Brussels 33
Redmond 32
Grafing 30
Guangzhou 28
Jinan 26
Milan 26
Phoenix 25
New York 23
Fuzhou 21
Fremont 20
Munich 20
Trieste 20
Redwood City 18
Nanchang 17
Venezia 17
Brno 16
Los Angeles 14
Dallas 13
Maserada Sul Piave 13
Hanover 12
Hebei 12
Zhengzhou 12
Toronto 11
Washington 11
Wuhan 11
Shanghai 10
Shenyang 10
Changsha 9
Helsinki 9
Ottawa 9
Vienna 9
Warsaw 9
Indiana 8
London 8
Rome 8
Sezze 8
Tappahannock 8
Turin 8
Brescia 7
Buenos Aires 7
Chongqing 7
Lappeenranta 7
Palermo 7
Simi Valley 7
Chengdu 6
Grugliasco 6
Xian 6
Baotou 5
Pune 5
Taizhou 5
Bologna 4
Clifton 4
Genoa 4
Hangzhou 4
Hong Kong 4
Monastir 4
Padova 4
Petritoli 4
Torre Del Greco 4
Auburn Hills 3
Budapest 3
Chicago 3
Edinburgh 3
Florence 3
Frankfurt am Main 3
Hyderabad 3
Lima 3
Majano 3
Montreal 3
Naples 3
Ningbo 3
Paris 3
Totale 23.114
Salva come PNG Salva come JPEG
Nome #
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 207
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 207
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 200
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 190
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 182
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 180
The management of multidrug-resistant enterobacteriaceae 171
Delafloxacin for the treatment of respiratory and skin infections 155
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 153
Hot topics in necrotising skin and soft tissue infections 148
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 147
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 147
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 146
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 140
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 140
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 138
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 135
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 135
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 134
Safety of long-term use of linezolid: Results of an open-label study 134
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 134
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 133
New therapeutic options for respiratory tract infections 133
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 132
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 132
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 132
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 131
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 131
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 130
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 130
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 130
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 130
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 128
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 128
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 128
The role of dalbavancin in skin and soft tissue infections 128
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 128
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 128
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 127
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 127
Impact of new treatment options for hepatitis c virus infection in liver transplantation 126
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 125
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 124
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 124
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 124
Development of novel antibacterial drugs to combat multiple resistant organisms 124
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 124
Linezolid underexposure in a patient co-treated with venlafaxine 123
Are prophylactic antifungals in highly colonized patients safe and effective? 123
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 122
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 122
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 122
Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy 122
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 121
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 121
Is there a future for tigecycline? 121
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study 121
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 121
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 121
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 120
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 120
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 120
Advances in antibiotic therapy in the critically ill 120
New therapeutic options for skin and soft tissue infections 120
New antibiotics for bad bugs: Where are we? 120
Prosthetic joints: Shining lights on challenging blind spots 120
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 120
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 120
Current and future therapies for invasive aspergillosis 119
Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety 119
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 119
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 119
Overview of Fungal Infections - The Italian Experience 119
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study 119
Schistosomiasis screening of travelers from italy with possible exposure in Corsica, France 118
Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 118
Safety profiles of old and new antimicrobials for the treatment of MRSA infections 117
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 117
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections 117
Ceftolozane/tazobactam: place in therapy 117
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 117
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study 116
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 116
SDD and colistin resistance: End of a dream? 116
Ten old antibiotics that will never disappear 116
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 116
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 115
Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: Proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site 115
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 114
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections 114
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria 114
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 114
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 114
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies 113
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: Focus on staphylococcus aureus 113
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 113
Is MIC increase of meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae correlated with the increase of resistance rates against some other antibiotics with Gram-negative activity? 113
Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey 113
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp 113
Hot topics in the diagnosis and management of skin and soft-tissue infections 113
Totale 12.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.650 0 312 411 1.456 861 1.502 1.204 1.004 855 412 195 438
2020/20215.163 164 589 236 592 341 663 329 524 523 246 474 482
2021/20222.808 175 220 223 157 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/2025161 137 24 0 0 0 0 0 0 0 0 0 0
Totale 29.932